rofecoxib has been researched along with Cancer of Esophagus in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two esophageal adenocarcinoma cell lines (SEG-1 and BIC) and two esophageal squamous cell cancer lines (KYSE 150 and KYSE 410) were treated with rofecoxib at doses ranging from 8." | 3.72 | Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1). ( Jackson, BJ; McFadden, DW; Riggs, DR; Vona-Davis, L, 2004) |
| "Carcinogenesis in Barrett's esophagus (BE) is associated with an increased expression of cyclooxygenase (COX) 2." | 1.31 | Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. ( Anderson, MA; Burgart, LJ; Buttar, NS; Krishnadath, KK; Leontovich, O; Lutzke, LS; Pacifico, RJ; Wang, KK; Westcott, JY, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vona-Davis, L | 1 |
| Riggs, DR | 1 |
| Jackson, BJ | 1 |
| McFadden, DW | 1 |
| Bardou, M | 1 |
| Barkun, AN | 1 |
| Ghosn, J | 1 |
| Hudson, M | 1 |
| Rahme, E | 1 |
| Buttar, NS | 1 |
| Wang, KK | 1 |
| Leontovich, O | 1 |
| Westcott, JY | 1 |
| Pacifico, RJ | 1 |
| Anderson, MA | 1 |
| Krishnadath, KK | 1 |
| Lutzke, LS | 1 |
| Burgart, LJ | 1 |
3 other studies available for rofecoxib and Cancer of Esophagus
| Article | Year |
|---|---|
Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
Topics: Adenocarcinoma; Apoptosis; Cell Division; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cycl | 2004 |
Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control | 2004 |
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
Topics: Adenocarcinoma; Animals; Barrett Esophagus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxyg | 2002 |